Cencora, Inc. has announced its definitive agreement to acquire a majority stake in OneOncology, a leading physician-driven platform for community oncology, aiming to enhance patient access to specialized cancer care and improve operational efficiencies within the oncology sector.

Target Information

Cencora, Inc., a prominent global pharmaceutical solutions provider, has announced its agreement to acquire a majority of the outstanding equity interests in OneOncology, a physician-led national platform dedicated to empowering independent oncology practices. This strategic acquisition builds on Cencora's existing stake in OneOncology, positioning both organizations to enhance their capabilities in community oncology.

Since its inception, OneOncology has gained traction by leveraging its physician-led approach, attracting renowned practices and professionals committed to delivering high-quality cancer care in local communities. The platform's growth aligns with Cencora’s pharmaceutical-centric strategy, designed to optimize patient access and streamline clinical operations for specialty physicians.

Industry Overview in the United States

The oncology sector in the United States has experienced significant transformations due to advancements in medical technologies and treatment protocols. Community oncology practices are increasingly essential to the healthcare system as they provide accessibl